Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 40326 - 40350 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Flavone	Approved Investigational	SOCS3	9021	upregulated	flavone results in increased expression of SOCS3 mRNA	17q25.3	A22625
Flecainide	Approved Investigational Withdrawn	AP1S1	1174	downregulated	Flecainide results in decreased expression of AP1S1 mRNA	7q22.1	A20430
Flecainide	Approved Investigational Withdrawn	ASAH1	427	upregulated	Flecainide results in increased expression of ASAH1 mRNA	8p22	A20438 A20430
Flecainide	Approved Investigational Withdrawn	ASNS	440	upregulated	Flecainide results in increased expression of ASNS mRNA	7q21.3	A20438 A20430
Flecainide	Approved Investigational Withdrawn	FABP1	2168	upregulated	Flecainide results in increased expression of FABP1 mRNA	2p11.2	A20438 A20430
Flecainide	Approved Investigational Withdrawn	FNDC4	64838	downregulated	Flecainide results in decreased expression of FNDC4 mRNA	2p23.3	A20430
Flecainide	Approved Investigational Withdrawn	FNDC4	64838	upregulated	Flecainide results in increased expression of FNDC4 mRNA	2p23.3	A20438 A20430
Flecainide	Approved Investigational Withdrawn	FOS	2353	upregulated	Flecainide results in increased expression of FOS mRNA	14q24.3	A20417
Flecainide	Approved Investigational Withdrawn	GDPD3	79153	upregulated	Flecainide results in increased expression of GDPD3 mRNA	16p11.2	A20438
Flecainide	Approved Investigational Withdrawn	HPN	3249	upregulated	Flecainide results in increased expression of HPN mRNA	19q13.11	A20430
Flecainide	Approved Investigational Withdrawn	INHBE	83729	upregulated	Flecainide results in increased expression of INHBE mRNA	12q13.3	A20438 A20430
Flecainide	Approved Investigational Withdrawn	LSS	4047	upregulated	Flecainide results in increased expression of LSS mRNA	21q22.3	A20430
Flecainide	Approved Investigational Withdrawn	NR0B2	8431	upregulated	Flecainide results in increased expression of NR0B2 mRNA	1p36.11	A20430
Flecainide	Approved Investigational Withdrawn	NUPR1	26471	upregulated	Flecainide results in increased expression of NUPR1 mRNA	16p11.2	A20438 A20430
Flecainide	Approved Investigational Withdrawn	SERPINA3	12	upregulated	Flecainide results in increased expression of SERPINA3 mRNA	14q32.13	A20438 A20430
Flecainide	Approved Investigational Withdrawn	SLC2A3	6515	downregulated	Flecainide results in decreased expression of SLC2A3 mRNA	12p13.31	A20438
Flecainide	Approved Investigational Withdrawn	SLC2A3	6515	upregulated	Flecainide results in increased expression of SLC2A3 mRNA	12p13.31	A20430
Flecainide	Approved Investigational Withdrawn	TAGLN	6876	downregulated	Flecainide results in decreased expression of TAGLN mRNA	11q23.2	A20430
Flecainide	Approved Investigational Withdrawn	WIPI1	55062	upregulated	Flecainide results in increased expression of WIPI1 mRNA	17q24.2	A20438 A20430
Fluconazole	Approved Investigational	STAR	6770	upregulated	Fluconazole results in increased expression of STAR mRNA	8p11.23	A22628
Fludarabine	Approved Investigational	BBC3	27113	upregulated	fludarabine results in increased expression of BBC3 mRNA	19q13.32	A22437
Fludarabine	Approved Investigational	CDKN1A	1026	upregulated	fludarabine results in increased expression of CDKN1A mRNA	6p21.2	A22629 A22437 A21623
Fludarabine	Approved Investigational	DNMT1	1786	downregulated	fludarabine results in decreased expression of DNMT1 mRNA	19p13.2	A21623
Fludarabine	Approved Investigational	FAS	355	upregulated	fludarabine results in increased expression of FAS mRNA	10q23.31	A21613
Fludarabine	Approved Investigational	GDF15	9518	upregulated	fludarabine results in increased expression of GDF15 mRNA	19p13.11	A22629

Displaying entries 40326 - 40350 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability